TGFB1 and cardiac hypertrophy: ADAMTS-16 promotes cardiac fibrosis and cardiac hypertrophy by activating the LAP-TGF-β signaling pathway through RRFR motifs, resulting in the cleavage of the LAP domain of LAP-TGF-β and the release of TGF-β [204].